Cell delivery patch for myocardial tissue engineering
Various types of stem cell therapeutics are being attempted for cardiac conditions. On the one hand, it is known that infarcts induce mobilization of stem cells, and that this may be part of an endogenous regenerative response. Accordingly, the intravenous administration of mesenchymal stem cells has demonstrated a regenerative activity in patients after heart attacks. This approach may be useful for other types of stem cells such as the Endometrial Regenerative Cells or cord blood derived mesenchymal stem cells, both of which can be used as allogeneic, off the shelf, products.
To read more...
http://www.stemcellpatents.com/patents-show-1316
Various types of stem cell therapeutics are being attempted for cardiac conditions. On the one hand, it is known that infarcts induce mobilization of stem cells, and that this may be part of an endogenous regenerative response. Accordingly, the intravenous administration of mesenchymal stem cells has demonstrated a regenerative activity in patients after heart attacks. This approach may be useful for other types of stem cells such as the Endometrial Regenerative Cells or cord blood derived mesenchymal stem cells, both of which can be used as allogeneic, off the shelf, products.
To read more...
http://www.stemcellpatents.com/patents-show-1316